{"url_path":"/sec/inm/8-k/2026-04-27/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 Entry into a Material Definitive","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1728328/0001213900-26-048064-index.html","accession_number":"0001213900-26-048064","cik":"0001728328","ticker":"INM","issuer_name":"InMed Pharmaceuticals Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1728328/0001213900-26-048064-index.html","primary_entity_key":"0001728328","primary_entity_name":"InMed Pharmaceuticals Inc."},"word_count":513,"has_tables":true,"body_markdown":"**Item 1.01 Entry into a Material Definitive\nAgreement.**\n\n** **\n\nPreferred Investment Option Amending Agreement\nwith Sabby Volatility Warrant Master Fund, Ltd.\n\n \n\nAs previously reported, pursuant to the terms\nof the Preferred Investment Options dated October 26, 2023 and June 26, 2025 (together, the “Sabby Preferred Investment Options”\nand each a “Sabby Preferred Investment Option”), InMed Pharmaceuticals Inc. (the “Company”) provided Sabby Volatility\nWarrant Master Fund, Ltd. (“Sabby”) with the right to subscribe for and purchase from the Company, in the aggregate, up to\n2,151,478 common shares in the capital of the Company at an exercise price per common share of $2.436, subject to adjustment (the “Sabby\nExercise Price”). The Sabby Preferred Investment Options were offered in private placements pursuant to Section 4(a)(2) of the Securities\nAct of 1933, as amended (the “Securities Act”), and Regulation D promulgated thereunder.\n\n \n\nOn April 21, 2026, the Company entered into a\nPreferred Investment Option Amending Agreement (the “Sabby Preferred Investment Option Amending Agreement”) with Sabby to\namend the Sabby Exercise Price contained in each Sabby Preferred Investment Option from $2.436 to $0.80.\n\n \n\nThe foregoing description of the Sabby Preferred\nInvestment Option Amending Agreement is not complete and is qualified in its entirety by the full text of the Sabby Preferred Investment\nOption Amending Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K (this “Report”) and\nincorporated herein by reference.\n\n \n\nPreferred Investment Option Amending Agreement\nwith Affiliates of H.C. Wainwright & Co., LLC\n\n \n\nAs previously reported, pursuant to the terms of Preferred Investment Options dated November 21, 2022, October 26, 2023 and June 26, 2025\n(together, the “Wainwright Preferred Investment Options” and each a “Wainwright Preferred Investment Option”),\nthe Company provided three affiliates of H.C. Wainwright & Co., LLC (“Wainwright” and, such affiliates of Wainwright,\nthe “Wainwright Parties” and each, a “Wainwright Party”) with the right to subscribe for and purchase from the\nCompany, in the aggregate, up to 153,236 common shares in the capital of the Company (on a post-consolidation basis) at an exercise price\nper common share of $82.50, $20.75 and $3.2013 (in each case, on a post-consolidation basis), respectively, subject to adjustment in each\ncase (together, the “Wainwright Exercise Prices”). The Wainwright Preferred Investment Options were offered in private placements\npursuant to Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder.\n\n \n\nOn April 24, 2026, the Company entered into Preferred Investment Option Amending Agreements (the “Wainwright Preferred Investment\nOption Amending Agreements”) with each Wainwright Party to amend the Wainwright Exercise Prices contained in each Wainwright Preferred\nInvestment Option to $0.80. \n\n \n\nThe foregoing description of the Wainwright Preferred Investment Option Amending Agreements is not complete and is qualified in its entirety\nby the full text of the Wainwright Preferred Investment Option Amending Agreements, a copy of a form of which is filed as Exhibit 10.2\nto this Report and incorporated herein by reference. The Wainwright Preferred Investment Option Amending Agreements are identical to each\nother except the names of the Wainwright Parties and the number of common shares that can be purchased by each Wainwright Party.\n\n \n\n1"}